![Clearside Biomedical, Inc. logo](/logos/CLSD.webp)
Clearside Biomedical, Inc.
NASDAQ:CLSD
Overview | Financials
Company Name | Clearside Biomedical, Inc. |
Symbol | CLSD |
Currency | USD |
Price | 0.978 |
Market Cap | 74,205,280 |
Dividend Yield | 0% |
52-week-range | 0.801 - 2.12 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D. |
Website | https://www.clearsidebio.com |
An error occurred while fetching data.
About Clearside Biomedical, Inc.
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD